YB1 Is a Major Contributor to Health Disparities in Triple Negative Breast Cancer

SIMPLE SUMMARY: Triple negative breast cancer (TNBC) is a devastating disease that affects many women, due to the lack of FDA-approved targeted therapy. In the absence of cell surface receptors ER, PR, and Her2 that can be targeted with hormonal and antibody treatments, cytotoxic chemotherapy remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Rana, Priyanka Shailendra, Wang, Wei, Alkrekshi, Akram, Markovic, Vesna, Khiyami, Amer, Chan, Ricky, Perzynski, Adam, Joseph, Natalie, Sossey-Alaoui, Khalid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699660/
https://www.ncbi.nlm.nih.gov/pubmed/34944882
http://dx.doi.org/10.3390/cancers13246262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699660/
https://www.ncbi.nlm.nih.gov/pubmed/34944882
http://dx.doi.org/10.3390/cancers13246262

Ejemplares similares